Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
GOSSAMER BIO, INC. (GOSS), most recent 12 months reported: revenue $53.29M, net loss $125.22M, free cash flow -$162.63M. Latest balance sheet on file: liquid cash $57.03M, total debt $36.15M, net cash $20.88M. From SEC filings. More on GOSSAMER BIO, INC.: Revenue · Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: Aquestive Therapeutics, Inc. · Tango Therapeutics, Inc. · Q32 Bio Inc. · Siga Technologies INC · OCULAR THERAPEUTIX, INC · Spero Therapeutics, Inc. · Biofrontera Inc. · INTEGRATED BIOPHARMA INC
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.